Related Experiment Videos
Positron emission tomography studies in parkinsonism
1Department of Neurology, North Shore University Hospital, Cornell University Medical College, Manhassett, New York.
Neurologic Clinics
|May 1, 1992
Summary
Positron Emission Tomography (PET) imaging aids in understanding parkinsonism
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Parkinsonism pathophysiology is complex.
- Functional neuroimaging with PET offers insights.
- Clinical utility of PET is expanding.
Purpose of the Study:
- To review the contribution of PET imaging in parkinsonism.
- To emphasize the growing clinical role of PET.
- To explore the potential of PET in diagnosis and management.
Main Methods:
- Review of existing literature on PET imaging in parkinsonism.
- Discussion of Fluorodeoxyglucose (FDG)/PET and F-dopa/PET techniques.
- Exploration of advancements in imaging modalities and statistical methods.
Main Results:
- FDG/PET is valuable for akinetic-rigid movement disorders assessment.
- F-dopa/PET provides in vivo insights into the nigrostriatal dopamine system.
- Advancements may simplify PET techniques for clinical use.
Conclusions:
- PET imaging, particularly FDG/PET and F-dopa/PET, significantly impacts parkinsonism diagnosis and management.
- Future developments promise broader clinical application and preclinical detection.
- PET techniques can aid in drug trials and monitoring disease progression.